SQI Diagnostics (CVE:SQD) will release its earnings data after the market closes on Wednesday, December 11th.

CVE SQD opened at C$0.06 on Monday. The company has a current ratio of 1.22, a quick ratio of 0.65 and a debt-to-equity ratio of 281.50. The firm’s fifty day moving average price is C$0.08 and its two-hundred day moving average price is C$0.12. SQI Diagnostics has a 1 year low of C$0.05 and a 1 year high of C$0.18. The firm has a market capitalization of $13.94 million and a P/E ratio of -1.36.

SQI Diagnostics Company Profile

SQI Diagnostics Inc, a life sciences company, develops and commercializes proprietary technologies and products for advanced multiplexing diagnostics in Canada. The company offers sqidworks diagnostic platform, a fully-automated microarray processing and analytical system; sqidlite benchtop diagnostic platform, a fully automated bench top microarray processing and analytical system; and sqid-X, a semi-automated bench-top platform.

Featured Article: Intrinsic Value and Stock Selection

Earnings History for SQI Diagnostics (CVE:SQD)

Receive News & Ratings for SQI Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SQI Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.